Assessment of Anesthesia Protocol for Patients Undergoing Fertility Preservation before Cancer Treatment
Published: 2024-04-29
Page: 224-230
Issue: 2024 - Volume 7 [Issue 1]
Kholoud Ibrahim Ali Saleh El Shehawy
Fakih IVF Fertility Center, Abu Dhabi, United Arab Emirates.
Eman Mohamed Ali Elshorbagy *
Al Dhannah Hospital, Al Dhannah City, Al Dhafra, Abu Dhabi, United Arab Emirates.
Mona Abdelrahman Mohammed Mohammed
Fakih IVF Fertility Center, Abu Dhabi, United Arab Emirates.
*Author to whom correspondence should be addressed.
Abstract
The preservation of fertility is a highly important consideration for patients undergoing cancer treatment, especially those requiring procedures such as egg retrieval or ovarian transplantation. These procedures pose unique challenges because they require anesthesia protocols that ensure patient safety while preserving fertility. Recent advances in anesthesia techniques offer promising opportunities to optimize the outcomes of fertility-sparing procedures. In recent years, there has been a shift toward alternative anesthesia methods, such as opting for regional anesthesia techniques such as spinal anesthesia and epidural anesthesia, and monitored anesthesia (MAC). These approaches have benefits such as reduced systemic impact, reduced recovery time, and improved postoperative pain management. Egg retrieval is an important step in preserving fertility for female cancer patients. Modern anesthesia protocols, particularly the use of regional techniques such as transvaginal ultrasound-guided paracervical blocks and spinal anesthesia, have been shown to improve patient comfort and safety during the procedure. This literature review aims to assess the effectiveness of modern anesthesia protocols in promoting successful fertility preservation in patients undergoing oocyte retrieval and ovarian transposition before cancer treatment. It will help reflect on the pros and cons that make these updated techniques an excellent choice to be utilized in such challenging situations.
Keywords: Fertility, fertility preservation, ovarian reserve, oocyte preservation, reproductive ages, uterine transplantation
How to Cite
Downloads
References
Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9:55.
Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women’s cancers: An unmet grand challenge in global health. Lancet Lond Engl. 2017;389(10071):847–60.
Sheikhalipour Z, Ghahramanian A, Fateh A, Ghiahi R, Onyeka TC. Quality of life in women with cancer and its influencing factors. J Caring Sci. 2019;8(1):9–15.
Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme, India. Indian J Med Res. 2022;156(4–5):598–607.
Jensen JR, Morbeck DE, Coddington CC. Fertility preservation. Mayo Clin Proc. 2011;86(1):45–9.
González C, Boada M, Devesa M, Veiga A. Concise review: Fertility preservation: An update. Stem Cells Transl Med. 2012;1(9):668–72.
Peterson AM, Singh M. Fertility preservation in benign and malignant conditions. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
[Cited 2024 Apr 6]. Available:http://www.ncbi.nlm.nih.gov/books/NBK576435/
Pinelli S, Basile S. Fertility preservation: Current and future perspectives for oncologic patients at risk for iatrogenic premature ovarian insufficiency. BioMed Res Int. 2018 Jul 11;2018:6465903.
Chen H, Liu C, Zhu S, Li S, Zhang Q, Song L, et al. The therapeutic effect of stem cells on chemotherapy-induced premature ovarian failure. Curr Mol Med. 2021;21(5):376–84.
Mauri D, Gazouli I, Zarkavelis G, Papadaki A, Mavroeidis L, Gkoura S, et al. Chemotherapy associated ovarian failure. Front Endocrinol. 2020;11:572388.
Wo JY, Viswanathan AN. The impact of radiotherapy on fertility, pregnancy, and neonatal outcomes of female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73(5):1304–12.
Marci R, Mallozzi M, Di Benedetto L, Schimberni M, Mossa S, Soave I, et al. Radiations and female fertility. Reprod Biol Endocrinol RBE. 2018;16:112.
Gao W, Liang JX, Yan Q. Exposure to radiation therapy is associated with female reproductive health among childhood cancer survivors: a meta-analysis study. J Assist Reprod Genet. 2015;32(8):1179–86.
Himpe J, Lammerant S, Van den Bergh L, Lapeire L, De Roo C. The impact of systemic oncological treatments on the fertility of adolescents and young adults—A systematic review. Life. 2023; 13(5):1209.
Waimey KE, Smith BM, Confino R, Jeruss JS, Pavone ME. Understanding fertility in young female cancer patients. J Womens Health. 2015;24(10):812–8.
Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol Off J Jpn Urol Assoc. 2010;17(4): 327–31.
Yumura Y, Takeshima T, Komeya M, Karibe J, Kuroda S, Saito T. Long-term fertility function sequelae in young male cancer survivors. World J Mens Health. 2023;41(2):255–71.
Rose BI. Approaches to oocyte retrieval for advanced reproductive technology cycles planning to utilize in vitro maturation: a review of the many choices to be made. J Assist Reprod Genet. 2014;31(11): 1409–19.
Estudillo E, Jiménez A, Bustamante-Nieves PE, Palacios-Reyes C, Velasco I, López-Ornelas A. Cryopreservation of gametes and embryos and their molecular changes. Int J Mol Sci. 2021;22(19): 10864.
Konc J, Kanyó K, Kriston R, Somoskői B, Cseh S. Cryopreservation of embryos and oocytes in human assisted reproduction. BioMed Res Int. 2014;2014:307268.
Prasath EB. Ovarian tissue cryopreservation: An update. J Hum Reprod Sci. 2008;1(2):50–5.
Rivas Leonel EC, Lucci CM, Amorim CA. Cryopreservation of human ovarian tissue: A review. Transfus Med Hemotherapy. 2019;46(3):173–81.
Santiago AE, Filho AL da S, Cândido EB, Ribeiro PA, Silva JCR e, Primo WQSP, et al. Perioperative management in gynecological surgery based on the ERAS program. RBGO Gynecol Obstet. 2022; 44(2):202–10.
Slavchev S, Yordanov A. Enhanced Recovery After Surgery (ERAS) protocol in minimally invasive gynecological surgery: a review of the literature. Pol Przegl Chir. 2022;95(3):1–5.
Peng J, Dong R, Jiao J, Liu M, Zhang X, Bu H, et al. Enhanced recovery after surgery impact on the systemic inflammatory response of patients following gynecological oncology surgery: A prospective randomized study. Cancer Manag Res. 2021;13:4383–92.
Bajsová S, Klát J. ERAS protocol in gynecologic oncology. Ceska Gynekol. 2019;84(5):376–85.
Bisch SP, Nelson G. Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review. Curr Oncol. 2022;29(2):631–40.
Morosan M, Popham P. Anaesthesia for gynaecological oncological surgery. Contin Educ Anaesth Crit Care Pain. 2014; 14(2):63–8.
Savant SS, Sriramkumar S, O’Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers. 2018;10(8):251.
Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, et al. Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecol Oncol. 2017;146(3):491–7.
Cybulska P, Goss C, Tew WP, Parameswaran R, Sonoda Y. Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecol Oncol. 2017; 146(2):416–26.
Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61(5):642–6.
Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc. 2019;29(4):651–68.
Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M, et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol. 2005; 97(1):90–5.
Lundin ES, Johansson T, Zachrisson H, Leandersson U, Bäckman F, Falknäs L, et al. Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. Acta Obstet Gynecol Scand. 2014; 93(4):335–44.
Di Donato V, Kontopantelis E, Aletti G, Casorelli A, Piacenti I, Bogani G, et al. Trends in mortality after primary cytoreductive surgery for ovarian cancer: A systematic review and metaregression of randomized clinical trials and observational studies. Ann Surg Oncol. 2017;24(6): 1688–97.
Kasaven LS, Jones BP, Keays R, Saso S. Anaesthetic considerations for fertility-sparing surgery and uterine transplantation. Anaesthesia. 2021;76 Suppl 4:46–55.